Occident Group

Lunaphore Technologies S.A. is a Swiss company developing next generation tissue autostainers for cancer research and tissue diagnostics. The award-winning technology based on microfluidics is called FFeX (Fast Fluidic Exchange). It aims to perform assays much faster than standard techniques and has demonstrated good results in tests with cancer patient samples. Lunaphore was founded in 2014 with the vision of bringing –omics like approaches to tissue analytics and has been recognized as one of the most innovative companies nationally and internationally.

Invasight is a clinical biotech company that focused on revolutionizing cell invasion research. The company was founded in 2019 and is headquartered in Zurich, Switzerland.

hemotune AG develops medical device for the purification of blood in acute care. The company uses magnetic blood purification on the device to treat infections. hemotune AG was founded in 2016 and is based in Zürich, Switzerland.

Lunaphore Technologies S.A. is a Swiss company developing next generation tissue autostainers for cancer research and tissue diagnostics. The award-winning technology based on microfluidics is called FFeX (Fast Fluidic Exchange). It aims to perform assays much faster than standard techniques and has demonstrated good results in tests with cancer patient samples. Lunaphore was founded in 2014 with the vision of bringing –omics like approaches to tissue analytics and has been recognized as one of the most innovative companies nationally and internationally.

hemotune AG develops medical device for the purification of blood in acute care. The company uses magnetic blood purification on the device to treat infections. hemotune AG was founded in 2016 and is based in Zürich, Switzerland.

Lunaphore Technologies S.A. is a Swiss company developing next generation tissue autostainers for cancer research and tissue diagnostics. The award-winning technology based on microfluidics is called FFeX (Fast Fluidic Exchange). It aims to perform assays much faster than standard techniques and has demonstrated good results in tests with cancer patient samples. Lunaphore was founded in 2014 with the vision of bringing –omics like approaches to tissue analytics and has been recognized as one of the most innovative companies nationally and internationally.

Resistell is a antibiotic resistance test.

Resistell is a antibiotic resistance test.

Lunaphore Technologies S.A. is a Swiss company developing next generation tissue autostainers for cancer research and tissue diagnostics. The award-winning technology based on microfluidics is called FFeX (Fast Fluidic Exchange). It aims to perform assays much faster than standard techniques and has demonstrated good results in tests with cancer patient samples. Lunaphore was founded in 2014 with the vision of bringing –omics like approaches to tissue analytics and has been recognized as one of the most innovative companies nationally and internationally.

InSphero AG develops organotypic biological 3D microtissues and microtissue-based assays for biochemical compounds screening and predictive drug testing applications. It offers human prostate and mammary carcinoma, and rat liver microtissues. The company also provides compound toxicity testing, cell-invasion assays, stem-cell research, cell-to-cell interaction, regenerative medicine, tissue engineering, and cell-to-extracellular matrix interaction services. In addition, it involves in study of transcriptomics, proteomics, and metabolomics. Further, the company provides custom development services, which include microtissue development, H and E stained paraffin sections, growth characteristics data, and morphometric data. Its microtissue system enables the generation of various model systems using either tumor-derived cells to reconstitute primary tumors or primary cells to mimic structure and function of diverse organ tissues. InSphero AG was founded in 2009 and is based in Zurich, Switzerland.

Numbrs is a customer-centric financial services company. It enables its customers to manage their existing bank accounts and personal finances and to buy any financial product from every provider at the best possible price. Numbrs is not a bank and will not become a bank. The company is headquartered in Zurich, Switzerland and employs over 100 people.

Lunaphore Technologies S.A. is a Swiss company developing next generation tissue autostainers for cancer research and tissue diagnostics. The award-winning technology based on microfluidics is called FFeX (Fast Fluidic Exchange). It aims to perform assays much faster than standard techniques and has demonstrated good results in tests with cancer patient samples. Lunaphore was founded in 2014 with the vision of bringing –omics like approaches to tissue analytics and has been recognized as one of the most innovative companies nationally and internationally.

Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, it originated as a spin-off from ETH Zurich. The company's lead candidate, VS-01, is in preclinical development and aims to address acute liver disease while supporting multiple failing organs, targeting three rare indications and having received Orphan Drug Designation for acute liver failure. Versantis also has products in its pipeline, including VS-02 and VS-03, which are designed to treat chronic liver diseases and drug intoxications, respectively. These treatments aim to meet significant unmet medical needs and have the potential to enhance patient outcomes across various medical fields.

Numbrs is a customer-centric financial services company. It enables its customers to manage their existing bank accounts and personal finances and to buy any financial product from every provider at the best possible price. Numbrs is not a bank and will not become a bank. The company is headquartered in Zurich, Switzerland and employs over 100 people.

iMusician is a Swiss based music start up offering musicians everything they need to sell, manage and monetise their music online. Run by a small, international team who are passionate about music, They do the hard work so you can concentrate on what’s important to you: making music!

InSphero AG develops organotypic biological 3D microtissues and microtissue-based assays for biochemical compounds screening and predictive drug testing applications. It offers human prostate and mammary carcinoma, and rat liver microtissues. The company also provides compound toxicity testing, cell-invasion assays, stem-cell research, cell-to-cell interaction, regenerative medicine, tissue engineering, and cell-to-extracellular matrix interaction services. In addition, it involves in study of transcriptomics, proteomics, and metabolomics. Further, the company provides custom development services, which include microtissue development, H and E stained paraffin sections, growth characteristics data, and morphometric data. Its microtissue system enables the generation of various model systems using either tumor-derived cells to reconstitute primary tumors or primary cells to mimic structure and function of diverse organ tissues. InSphero AG was founded in 2009 and is based in Zurich, Switzerland.

iMusician is a Swiss based music start up offering musicians everything they need to sell, manage and monetise their music online. Run by a small, international team who are passionate about music, They do the hard work so you can concentrate on what’s important to you: making music!